Page last updated: 2024-12-11

adenosine 5'-phosphorothioate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

adenosine 5'-phosphorothioate: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6913230
CHEMBL ID574816
SCHEMBL ID1091093
MeSH IDM0062762

Synonyms (19)

Synonym
adenosine 5'-phosphorothioate
SRA ,
amp-s
CHEMBL574816
(2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-(dihydroxyphosphinothioyloxymethyl)oxolane-3,4-diol
19341-57-2
5'-(dihydrogen phosphorothioate)adenosine
adenosine 5'-o-thiomonophosphate
thiophosphoryl adenylic acid
adenosine 5'-thiophosphate
adenosine -5'-thio-monophosphate
SCHEMBL1091093
adenosine phosphorothioate
DTXSID30172946
5'-o-thiophosphonoadenosine
Q27465464
o-(((2r,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl) o,o-dihydrogen phosphorothioate
o-(((2r,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)o,o-dihydrogenphosphorothioate
adenosine 5/'-o-thiomonophosphate dilithium salt
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID1132763Antiplatelet activity in sheep platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation pretreated for 2.5 mins followed by ADP addition by photometric analysis relative to adenosine1978Journal of medicinal chemistry, Jun, Volume: 21, Issue:6
New inhibitors of platelet aggregation. 5'-Phosphate, 5'-phosphorothioate, and 5'-O-sulfamoyl derivatives of 2-substituted adenosine analogues.
AID440578Dissociation constant, pKa in solution2009Journal of medicinal chemistry, Sep-10, Volume: 52, Issue:17
Identification of critical ligand binding determinants in Mycobacterium tuberculosis adenosine-5'-phosphosulfate reductase.
AID1321605Retention time of compound by RP-HPLC analysis2016Bioorganic & medicinal chemistry, 11-01, Volume: 24, Issue:21
Phosphorothioate analogs of P1,P3-di(nucleosid-5'-yl) triphosphates: Synthesis, assignment of the absolute configuration at P-atoms and P-stereodependent recognition by Fhit hydrolase.
AID440577Dissociation constant, pKa at pH 6 to 9.52009Journal of medicinal chemistry, Sep-10, Volume: 52, Issue:17
Identification of critical ligand binding determinants in Mycobacterium tuberculosis adenosine-5'-phosphosulfate reductase.
AID150466Compound was evaluated for its agonistic activity towards P2Y purinoceptor 1 in turkey erythrocyte membranes; NE=No effect1999Journal of medicinal chemistry, Sep-09, Volume: 42, Issue:18
2-thioether 5'-O-(1-thiotriphosphate)adenosine derivatives as new insulin secretagogues acting through P2Y-Receptors.
AID440574Binding affinity to Mycobacterium tuberculosis adenosine-5'-phosphosulfate reductase assessed as S-sulfocysteine formation at pH 5.5 by single turnover method in absence of thioredoxin2009Journal of medicinal chemistry, Sep-10, Volume: 52, Issue:17
Identification of critical ligand binding determinants in Mycobacterium tuberculosis adenosine-5'-phosphosulfate reductase.
AID1132769Antiplatelet activity in sheep platelet rich plasma assessed as inhibition of serotonin-induced platelet aggregation pretreated for 1 min followed by serotonin addition by photometric analysis1978Journal of medicinal chemistry, Jun, Volume: 21, Issue:6
New inhibitors of platelet aggregation. 5'-Phosphate, 5'-phosphorothioate, and 5'-O-sulfamoyl derivatives of 2-substituted adenosine analogues.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (43)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (37.21)18.7374
1990's5 (11.63)18.2507
2000's7 (16.28)29.6817
2010's14 (32.56)24.3611
2020's1 (2.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.83

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.83 (24.57)
Research Supply Index3.81 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.83)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (2.27%)4.05%
Observational0 (0.00%)0.25%
Other43 (97.73%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]